China
Africa
Explore chapters and articles related to this topic
Breast imaging
Published in A Stewart Whitley, Jan Dodgeon, Angela Meadows, Jane Cullingworth, Ken Holmes, Marcus Jackson, Graham Hoadley, Randeep Kumar Kulshrestha, Clark’s Procedures in Diagnostic Imaging: A System-Based Approach, 2020
A Stewart Whitley, Jan Dodgeon, Angela Meadows, Jane Cullingworth, Ken Holmes, Marcus Jackson, Graham Hoadley, Randeep Kumar Kulshrestha
Open surgical biopsy is thus avoided. While FNA or CBx can be done freehand in palpable lesions, impalpable lesions produce unique problems. In recent years FNA has been replaced by CBx in many centres, utilising a wide gauge (14) core cut or 11 gauge mammotome device for diagnosis.
Complications of Breast Surgery
Published in Stephen M. Cohn, Matthew O. Dolich, Complications in Surgery and Trauma, 2014
Sayl Bunyan Al-Saedi, Ismail Jatoi
For nonpalpable lesions: Options include ultrasound (US)-guided fine-needle aspiration cytology (FNAC), core needle biopsy (CNB) with US or stereotactic guidance, vacuum-assisted stereotactic (mammotome) CNB, and excisional biopsy with US-guided or mammographically assisted needle localization.
Breast imaging
Published in David A Lisle, Imaging for Students, 2012
Core biopsy may be performed under US or mammographic guidance with 14–18 gauge cutting needles that obtain a core of tissue for histological diagnosis. A variation of core biopsy is vacuum-assisted core biopsy (Mammotome®). A Mammotome consists of an 11 gauge probe that is positioned under mammographic control. A vacuum pulls a small sample of breast tissue into the probe; this is cut off and transported back through the probe into a specimen chamber. This technique is particularly useful for microcalcification.
New Insights of Corynebacterium kroppenstedtii in Granulomatous Lobular Mastitis based on Nanopore Sequencing
Published in Journal of Investigative Surgery, 2022
Xin-Qian Li, Jing-Ping Yuan, Ai-Si Fu, Hong-Li Wu, Ran Liu, Tian-gang Liu, Sheng-Rong Sun, Chuang Chen
A total of 50 GLM women were selected in the study (Table 1). The mean age of these patients was 32.7 years (range 20–56 years), and most (88%) of them were under 40 years. The majority had a history of childbearing (96.0%) and lactation (84.0%), and 80.0% patients showed symptoms within five years of delivery. Three patients (6.0%) had a family history of breast cancer. One patient had a pituitary tumor. Five patients (10.0%) had psychiatric disorders. Both breasts were affected in five patients (10.0%). The main presentation was a painful breast mass. Two cases were complicated with erythema nodosum of the lower limbs. Histological diagnosis was based on mammotome biopsy (48.0%) and core needle biopsy (32.0%). Six patients (12.0%) underwent core needle biopsy (4.0%) and excisional biopsy (8.0%) at a local hospital; four patients (8.0%) did not undergo biopsy. Fresh samples, including pus (86.0%) and tissue (14.0%), were used for bacterial detection. Twenty-four patients (48.0%) were at the early stage, and twenty-six patients (52.0%) were at the late stage. The median follow-up time was 12 months (7–31 months). Four patients (8.0%) experienced relapse during follow-up.
Microwave ablation of benign breast tumors: a prospective study with minimum 12 months follow-up
Published in International Journal of Hyperthermia, 2018
Jinshun Xu, Han Wu, Zhiyu Han, Jing Zhang, Qinying Li, Jianping Dou, Chao An, Erpeng Qi, Jie Yu, Ping Liang
Exclusion criteria included: (a) patients with contraindications on examination of CEUS or CEMR; (b) patients in pregnancy or lactation; (c) patients with evidence of coagulopathy, severe cardiopulmonary dysfunction, chronic liver diseases and (or) renal failure; (d) patients during menstrual period; (e) patients referring to other therapies such as surgical resection and mammotome.